World-first clinical trial of cannabis for chemotherapy patients kicks off in NSW

Sydney Morning Herald

5 December 2016 - Lauren Hew knows she'll be fighting cancer until it wins.

The 32-year-old mother of two was diagnosed with Ewing sarcoma in 2014. After a year-and-a-half in remission the cancer came back.

The randomised, placebo-controlled, double-blinded trial will test whether cannabis in the form of an oral, plant-derived capsule could be a safe and effective treatment.

Doctor have begun recruiting patients for the pioneering initiative championed by the NSW government, which aims to enrol more than 300 chemotherapy patients who do not respond to anti-nausea medication.

Some 80 patients will be recruited for in stage one of the trial conducted by the Chris O'Brien Lifehouse, in partnership with the University of Sydney, the Royal Prince Alfred Hospital and other major NSW cancer centres.

Read Sydney Morning Herald article 

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Australia , Clinical trial